Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program Clinical research trials and Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program. Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program clinical trial. Participants typically obtain the most effective healthcare available for their Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "F" Clinical Trials Conditions > Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program

Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program



Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program

For Condition: Prostate Cancer
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , Urological Research Foundation
Synopsis: There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination
Details:
Eligibility:
Study Type:
  Observational, Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Minimum Age/Maximum Age: 40 Years/
Genders: Male
Protocol Entry Criteria: Men with prostate cancer diagnosed through the PSA screening study
Total Enrollment: 

Location and Contact Information:

Washington University School of Medicine
St. Louis,  Missouri,  63110
United States
 


Additional Information:
Study ID Numbers:
  NCRR-M01RR00036-0838; 
Study Start Date: 
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035217

Other Prostate Cancer Studies:
1. Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated with One Cytotoxic Chemotherapy Regimen

2. Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

3. Vaccine Therapy in Treating Patients With Gastric Cancer, Non-Small Cell Lung Cancer, Prostate, or Ovarian Cancer

4. Flavopiridol in Treating Patients With Refractory Cancer

5. Safety and Efficacy Study of Omnitarg (Pertuzumab) to Treat Castration-Resistant Prostate Cancer

Related Studies:

Other Prostate Cancer Clinical Trials
Other Missouri Clinical Trials
Other St. Louis Clinical Trials

Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program

Modify your Search

  Other Prostate Cancer Clinical Trials
  Other Missouri Clinical Trials
  Other St. Louis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103